IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Phytochem Remedies (India) IPO is a Book Building listing on BSE SME exchange, with an ipo size of ₹ [●] Cr. The company is based in Ajmer and caters to Steel - Iron sector. Sobhagya Capital Options is the merchant banker of Phytochem Remedies (India) IPO. It is a SME Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 26th June 2025.
Phytochem Remedies (India) IPO posted revenues of ₹ 194.40 crores and PAT of ₹ 14.16 crores in FY25 on annualised basis.
Revenue:
₹ 194.40 Cr.
EBITDA Margin:
8.11
% 
Net Worth: ₹ 27.36 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: 0.26 times
Financial results of Phytochem Remedies (India) IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
| Financials | FY25 | FY24 | FY23 | ||
|---|---|---|---|---|---|
|
Balance Sheet
|
|||||
| Assets | 54.06 | 55.48 | 35.31 | ||
| Net Worth | 27.36 | 13.20 | 3.86 | ||
| Total Debt | 4.76 | 12.38 | 9.53 | ||
|
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
194.40 | 248.19 | 175.07 | ||
EBITDA
EBITDA on annualised basis |
15.77 | 7.12 | 1.22 | ||
PAT
PAT on annualised basis |
14.16 | 9.34 | 2.88 | ||
Phytochem Remedies (India) IPO PAT Margin is 7.28 % , ROCE (Return on Capital Employed) is 61.50 % as per latest financial. The below table shows Phytochem Remedies (India) IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
| Particulars | FY25 | FY24 | FY23 |
|---|---|---|---|
| EBITDA Margin (%) | 8.11 | 2.87 | 0.70 |
| PAT Margin (%) | 7.28 | 3.76 | 1.65 |
| EPS (₹) | 11.83 | 7.80 | 2.41 |
| ROE (%) | 51.75 | 70.76 | 74.61 |
| ROCE (%) | 61.50 | 51.20 | 34.43 |
| ROA (%) | 26.19 | 16.83 | 8.16 |
| Debt to Equity | 0.17 | 0.94 | 2.47 |
The market Capitalisation of Phytochem Remedies (India) IPO is ₹ [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Phytochem Remedies (India) IPO prospectus highlights an Return on Equity (ROE) of 51.75 % , Return on Assets (ROA) of 26.19 %, and an EBITDA Margin of 8.11 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Phytochem Remedies (India) IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Phytochem Remedies (India) IPO is ₹ [●] Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Phytochem Remedies (India) IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Phytochem Remedies (India) IPO reported revenue of ₹ 194.40 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Phytochem Remedies (India) IPO provide insights into sales growth, market demand, and business scalability.
Phytochem Remedies (India) recorded an EBITDA of ₹ 15.77 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Phytochem Remedies (India) Profit After Tax (PAT) is ₹ 14.16 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 194.40 Cr.
EBITDA Margin:
8.11
%
Net Worth: ₹ 27.36 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: 0.26 times
Phytochem Remedies (India) operates in Steel - Iron and Trading Of Ferro Alloys, Including High-carbon Silico Manganese, Manganese Ore, And Highcarbon Ferro Manganese. The Issue is listed on BSE SME in Jul, 2025. Phytochem Remedies (India) IPO size was with Issue price of .
Merchant Banker(s) of Phytochem Remedies (India) IPO: Sobhagya Capital Options Limited
Phytochem Remedies (India) IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Phytochem Remedies (India) IPO listed at a listing price of against the offer price of .
The current market price of Phytochem Remedies (India) is .
Why Us?
